2,378
Views
13
CrossRef citations to date
0
Altmetric
Editorial

Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity

, &

Bibliography

  • Silberstein SD, Marcus DA. Sumatriptan: treatment across the full spectrum of migraine. Expert Opin Pharmacother 2013;14:1659-67
  • Lionetto L, Negro A, Casolla B, et al. Sumatriptan succinate: pharmacokinetics of different formulations in clinical practice. Expert Opin Pharmacother 2012;13:2369-80
  • Mitsikostas DD, Knight YE, Lasalandra M, et al. Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? J Headache Pain 2011;12:411-17
  • Arora A, Arora S. Spontaneous splenic infarction associated with sumatriptan use. J Headache Pain 2006;7:214-16
  • Tfelt-Hansen PC. Does sumatriptan cross the blood-brain barrier in animals and man? J Headache Pain 2010;11:5-12
  • Tepper S, Allen C, Sanders D, et al. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. Headache 2003;43:44-8
  • Blier P, Bergeron R. The safety of concomitant use of sumatriptan and antidepressant treatments. J Clin Psychopharmacol 1995;15:106-9
  • Tepper SJ. Serotonin syndrome: SSRIs, SNRIs, triptans, and current clinical practice. Headache 2012;52:195-7
  • Camarena B, Aguilar A, Loyzaga C, et al. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int J Neuropsychopharmacol 2004;7:49-53
  • Zohar J, Chopra M, Sasson Y, et al. Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2000;1:92-100
  • Pian KL, Westenberg HG, van Megen HJ, et al. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder. Psychopharmacology (Berl) 1998;140:365-70
  • Stern L, Zohar J, Cohen R, et al. Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan. Eur Neuropsychopharmacol 1998;8:325-8
  • Lionetto L, Negro A, Palmisani S, et al. Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs 2012;17:393-406
  • Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55:754-62
  • Sarchielli P, Granella F, Prudenzano MP, et al. Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 2012;13(Suppl 2):S31-70

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.